Arbuthnot Banking Group plc (LON:ARBB) 2022 results delivered the expected strong profit and franchise growth (pre-tax profit up from £4.6m to £20m). Core business profitability increased primarily because of widening
Tissue Regenix Group plc (LON:TRX) is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a
With Fidelity Special Values plc (LON:FSV) having recently reached a decade of outperformance under fund manager Alex Wright’s stewardship, we look at what has made this happen. We outline the
Our recent notes explored why investor concerns over the whole Chinese market appeared overdone. With the recent rise in these markets, it appears that these disquiets have moderated. Accordingly, in
City of London Investment Group plc (LON:CLIG) has announced its interim results for 1H’23. The headline figures were in line with those from the January trading statement. As previously indicated,
CyanConnode is currently involved in Indian tenders for more than 100m meter endpoints, and its partners have already secured L1 preferred bidder status for c.30m incremental meters. In addition to
Oakley Capital Investments Limited (LON:OCI) January trading statement announced NAV (662p per share), total NAV return (24%), NAV growth driven by EBITDA growth (65%), modest multiple expansion (35%), investments (£271m),
The full-year results to Dec’22 reconfirmed the core strengths of Apax Global Alpha plc (LON:APAX), notably i) Apax enhances the operational performance of its investments ‒ revenue and EBITDA growth
The November 2022 factsheet gave some key information, including the NAV (469.5p), NAV return (4%), net cash generation (£34m), distributions (£111.5m), calls (£77.5m), period-end cash (£52m) and commitments (£848m, including
In our most recent note, Continued resilience in difficult markets | Hardman & Co (hardmanandco.com), published on 23 November 2022, we analysed how Fidelity European Trust plc (LON:FEV) had performed
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
